Bill Text: CA SB962 | 2021-2022 | Regular Session | Amended
Bill Title: Healing arts: clinical laboratory technology: moderate-complexity laboratories.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2022-05-19 - May 19 hearing: Held in committee and under submission. [SB962 Detail]
Download: California-2021-SB962-Amended.html
|
Amended
IN
Senate
April 05, 2022 |
CALIFORNIA LEGISLATURE—
2021–2022 REGULAR SESSION
Senate Bill
No. 962
| Introduced by Senator Jones |
February 09, 2022 |
An act to amend Section 1209 of the Business and Professions Code, relating to healing arts.
LEGISLATIVE COUNSEL'S DIGEST
SB 962, as amended, Jones.
Healing arts: clinical laboratory technology: moderate-complexity laboratories.
Existing law provides for the licensure, registration, and regulation of clinical laboratories and various clinical laboratory personnel by the State Department of Public Health. For these purposes, existing law defines “laboratory director” and imposes prescribed requirements on those individuals, including requiring that a laboratory director for a clinical laboratory of an acute care hospital be a physician and surgeon who is a qualified pathologist, subject to specified exceptions. Existing law allows a laboratory director, if they possess certain qualifications, to perform the duties of a technical consultant, among other specified positions, or to delegate these responsibilities to persons qualified, as specified. Existing law makes a violation of these provisions a
crime.
For purposes of a moderate-complexity laboratory, this bill would expand the definition of a “laboratory director” to include an individual who meets specified requirements and guidelines.
the College of American Pathologists guidelines. The bill would authorize an individual who meets the College of American Pathologists guidelines to operate as a technical consultant in a moderate-complexity laboratory. With respect to the above-specified exceptions concerning a laboratory director for a clinical laboratory of an acute care hospital, the bill would expand those exceptions, as specified. The bill would authorize a laboratory director to operate as a technical consultant in a moderate-complexity laboratory if certain conditions are met. Because a violation of these provisions would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish
procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Digest Key
Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: YESBill Text
The people of the State of California do enact as follows:
SECTION 1.
Section 1209 of the Business and Professions Code is amended to read:1209.
(a) As used in this chapter, “laboratory director” means any person who is any of the following:(1) A duly licensed physician and surgeon.
(2) Only for purposes of a clinical laboratory test or examination classified as waived, is any of the following:
(A) A duly licensed clinical laboratory scientist.
(B) A duly licensed limited clinical laboratory scientist.
(C) A duly licensed naturopathic doctor.
(D) A
duly licensed optometrist serving as the director of a laboratory that only performs clinical laboratory tests authorized pursuant to former paragraph (10) of subdivision (d) of Section 3041.
(E) A duly licensed dentist serving as the director of a laboratory that performs only clinical laboratory tests authorized within the scope of practice of dentistry as delineated under Section 1625.
(F) A pharmacist-in-charge of a pharmacy serving as the director of a laboratory that only performs tests waived pursuant to the federal Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. Sec. 263a), as authorized by the Pharmacy Law (Chapter 9 (commencing with Section 4000)).
(G)For purposes of operating a moderate-complexity laboratory, an individual who meets the College of American Pathologist guidelines, which may include, but is not limited to, a respiratory care practitioner that performs clinical laboratory tests in accordance with Chapter 8.3 (commencing with Section 3700).
(3) Licensed to direct a clinical laboratory under this chapter.
(4) For purposes of operating a moderate-complexity laboratory, an individual who meets the College of American Pathologists guidelines, which may include, but is not limited to, a respiratory care practitioner who performs clinical laboratory tests in accordance with Chapter 8.3 (commencing with Section 3700).
(b) (1) A person defined in paragraph (1) or (3) of subdivision (a) who is identified as the CLIA laboratory director of a laboratory that performs clinical laboratory tests classified as moderate or high complexity shall also meet the laboratory director qualifications under CLIA for the type and complexity of tests being offered by
the laboratory.
(2) As used in this subdivision, “CLIA laboratory director” means the person identified as the laboratory director on the CLIA certificate issued to the laboratory by the federal Centers for Medicare and Medicaid Services (CMS).
(c) (1) The laboratory director, if qualified under CLIA, may perform the duties of the technical consultant, technical supervisor, clinical consultant, general supervisor, and testing personnel, or delegate these responsibilities to persons qualified under CLIA. If the laboratory director reapportions performance of those responsibilities or duties, they shall remain responsible for ensuring that all those duties and
responsibilities are properly performed.
(2) An individual who meets the College of American Pathologists guidelines, which may include, but is not limited to, a respiratory care practitioner who performs clinical laboratory tests in accordance with Chapter 8.3 (commencing with Section 3700), may operate as a technical consultant in a moderate-complexity laboratory.
(d) (1) The laboratory director is responsible for the overall operation and administration of the clinical laboratory, including administering the technical and scientific operation of a clinical laboratory, the selection and supervision of procedures, the reporting of results, and active participation in its operations to the extent necessary
to ensure compliance with this act and CLIA. They shall be responsible for the proper performance of all laboratory work of all subordinates and shall employ a sufficient number of laboratory personnel with the appropriate education and either experience or training to provide appropriate consultation, properly supervise and accurately perform tests, and
report test results in accordance with the personnel qualifications, duties, and responsibilities described in CLIA and this chapter.
(2) Where a point-of-care laboratory testing device is utilized and provides results for more than one analyte, the testing personnel may perform and report the results of all tests ordered for each analyte for which they have been found by the laboratory director to be competent to perform and report.
(e) As part of the overall operation and administration, the laboratory director of a registered laboratory shall document the adequacy of the qualifications (educational background, training, and experience) of the personnel directing and supervising the laboratory and performing the laboratory test procedures and examinations. In
determining the adequacy of qualifications, the laboratory director shall comply with any regulations adopted by the department that specify the minimum qualifications for personnel, in addition to any CLIA requirements relative to the education or training of personnel.
(f) As part of the overall operation and administration, the laboratory director of a licensed laboratory shall do all of the following:
(1) Ensure that all personnel, prior to testing biological specimens, have the appropriate education and experience, receive the appropriate training for the type and complexity of the services offered, and have demonstrated that they can perform all testing operations reliably to provide and report accurate results. In determining the adequacy of qualifications, the laboratory
director shall comply with any regulations adopted by the department that specify the minimum qualifications for, and the type of procedures that may be performed by, personnel in addition to any CLIA requirements relative to the education or training of personnel. Any regulations adopted pursuant to this section that specify the type of procedure that may be performed by testing personnel shall be based on the skills, knowledge, and tasks required to perform the type of procedure in question.
(2) Ensure that policies and procedures are established for monitoring individuals who conduct preanalytical, analytical, and postanalytical phases of testing to ensure that they are competent and maintain their competency to process biological specimens, perform test procedures, and report test results promptly and proficiently, and, whenever
necessary, identify needs for remedial training or continuing education to improve skills.
(3) Specify in writing the responsibilities and duties of each individual engaged in the performance of the preanalytic, analytic, and postanalytic phases of clinical laboratory tests or examinations, including which clinical laboratory tests or examinations the individual is authorized to perform, whether supervision is required for the individual to perform specimen processing, test performance, or results reporting, and whether consultant, supervisor, or director review is required prior to the individual reporting patient test results.
(g) The competency and performance of staff of a licensed laboratory shall be evaluated and documented by the laboratory director, or by a person
who qualifies as a technical consultant or a technical supervisor under CLIA depending on the type and complexity of tests being offered by the laboratory.
(1) The procedures for evaluating the competency of the staff shall include, but are not limited to, all of the following:
(A) Direct observations of routine patient test performance, including patient preparation, if applicable, and specimen handling, processing, and testing.
(B) Monitoring the recording and reporting of test results.
(C) Review of intermediate test results or worksheets, quality control records, proficiency testing results, and preventive maintenance records.
(D) Direct observation of performance of instrument maintenance and function checks.
(E) Assessment of test performance through testing previously analyzed specimens, internal blind testing samples, or external proficiency testing samples.
(F) Assessment of problem solving skills.
(2) Evaluation and documentation of staff competency and performance shall occur at least semiannually during the first year an individual tests biological specimens. Thereafter, evaluations shall be performed at least annually unless test methodology or instrumentation changes, in which case, prior to reporting patient test results, the individual’s performance shall be reevaluated to include
the use of the new test methodology or instrumentation.
(h) The laboratory director of each clinical laboratory of an acute care hospital shall be a physician and surgeon who is a qualified pathologist, except as follows:
(1) If a qualified pathologist is not available, a physician and surgeon or a clinical laboratory bioanalyst qualified as a laboratory director under subdivision (a) may direct the laboratory. However, a qualified pathologist shall be available for consultation at suitable intervals to ensure high-quality service.
(2) (A) If there are two or more clinical laboratories of an acute care hospital, those additional clinical laboratories that are limited to the performance of blood gas analysis,
blood electrolyte analysis, or related analyte analysis related respiratory analyte analysis, or analysis of any analyte that is measured by a blood gas analyzer may be directed by either of the following:
(i) A physician and surgeon qualified as a laboratory director under subdivision (a), irrespective of whether a pathologist is available. (a).
(ii) An individual with a doctorate degree who is qualified as a laboratory director under
subdivision (a), irrespective of whether a pathologist is available. (a).
(B) As used in this subdivision, a qualified pathologist is a physician and surgeon certified or eligible for certification in clinical or anatomical pathology by the American Board of Pathology or the American Osteopathic Board of Pathology.
(C) As used in this subdivision, an individual with a doctorate degree is an individual who holds a Ph.D. in a biological, chemical, physical, or clinical laboratory science, as specified by the College of American Pathologists guidelines for moderate-complexity laboratories.
(i) Subdivision (h) does not apply to any director of a clinical laboratory of an acute care hospital acting in that capacity on or before January 1, 1988.
(j) A laboratory director may serve as the director of up to the maximum number of laboratories stipulated by CLIA, as defined under Section 1202.5.
(k)A laboratory director may operate as a technical consultant in a moderate-complexity laboratory if both of the following conditions are met:
(1)The director is a respiratory care practitioner practicing in accordance with Chapter 8.3 (commencing with Section 3700).
(2)The director meets the
College of American Pathologists guidelines.
